top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

BARCELONA, Spain – Tuesday 2 September: One year of treatment with the highest dose of the cholesterol-lowering drug rosuvastatin can shrink plaque inside the arteries of patients who have had ...

Date : 02/09/2014
Escardio

Renowned expert, Professor Eugene Braunwald (Brigham and Women’s Hospital and Harvard Medical School, Boston, USA) speaks to ESC Congress News about the options. “LDL-C is the principal ...

Date : 27/08/2017
Escardio

Having high cholesterol levels (hyperlipidaemia) is a major risk factor for the development of blocked arteries (atherosclerosis) and heart disease, and, therefore, lowering cholesterol via drugs, ...

Date : 11/03/2010
Escardio

Emerging evidence indicates that plasma levels of PCSK9 predict recurrent cardiovascular events, for example myocardial infarction and angina, in patients with coronary artery disease, even in those ...

Date : 27/08/2017
Escardio

Heterozygous familial hypercholesterolaemia (FH) is a life-threatening genetic condition linked with a high risk of premature cardiovascular disease, including heart attack and stroke. Elevated LDL ...

Date : 01/09/2019
Escardio

Physical inactivity, smoking, high blood pressure, diabetes, and high cholesterol play a greater role than genetics in many young patients with heart disease, according to research presented today at ...

Date : 02/09/2019